Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 14q24 1q24 3 Microdeletion Syndrome C4750911
Clinical comparison between 2p13 2 Microdeletion Syndrome and 14q24 1q24 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
14q24 1q24 3 Microdeletion Syndrome C4750911
A rare genetic deletion involving part of chromosome 14. It can affect development and lead to various medical issues. Management focuses on supportive care and addressing specific needs.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
14q24 1q24 3 Microdeletion Syndrome C4750911
0-null
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
14q24 1q24 3 Microdeletion Syndrome C4750911
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
14q24 1q24 3 Microdeletion Syndrome C4750911
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
14q24 1q24 3 Microdeletion Syndrome C4750911
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
14q24 1q24 3 Microdeletion Syndrome C4750911
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
14q24 1q24 3 Microdeletion Syndrome C4750911
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 14q24-1q24-3-microdeletion-syndrome-C4750911 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 14q24 1q24 3 Microdeletion Syndrome C4750911 | Discriminating power |
|---|---|---|---|
| Chromosomal region | A small missing segment at 2p13.2 is described. | A deletion involving 14q24.1 to 14q24.3 is described. | High |
| Severity label | Source data label the condition severe, without defining features. | Source data label the condition moderate, without defining features. | Moderate |
| Clinical pattern | Features vary by affected genes; no definitive symptoms are supplied. | Development and varied medical issues may occur; specifics are not supplied. | Low |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
Testing identifies a 2p13.2 deletion
The chromosome region matches the left concept.
High
A severe congenital presentation needs genetic classification
Severity labeling may fit, but clinical confirmation is required.
Low
Counseling concerns chromosome 2
Discussion should focus on the reported chromosome 2 segment.
Moderate
Choose 14q24 1q24 3 Microdeletion Syndrome C4750911 when
Testing identifies a 14q24.1q24.3 deletion
The chromosome interval matches the right concept.
High
Developmental concerns suggest a chromosome 14 deletion
This is consistent with the sparse description, not diagnostic alone.
Low
Supportive-care planning is the main need
The source emphasizes supportive care and individual needs.
Moderate
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 14q24 1q24 3 Microdeletion Syndrome C4750911 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect a 2p13.2 copy-number loss. | May detect a 14q24.1q24.3 copy-number loss. | Region and genes involved require laboratory and clinician review. |
| Karyotype or targeted FISH | May or may not detect a small 2p deletion. | May or may not detect the 14q interval. | A normal result does not exclude a microdeletion. |
| Clinical genetics assessment | Correlates findings with chromosome 2 genes. | Correlates findings with chromosome 14 genes. | Neither test result alone establishes the full phenotype. |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established in the supplied data.
- Factors
- Reported severe label, affected genes, and individual findings may matter.
14q24 1q24 3 Microdeletion Syndrome C4750911
- Outcome
- Long-term outcome is not established in the supplied data.
- Factors
- Reported moderate label, deletion extent, and developmental needs may matter.
Time frame: Congenital and chronic; exact course is unknown.
Clinician interpretation is required; mortality and prognosis should not be inferred.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental difficulties | Possible but not specifically established. Development may be affected; details are not supplied. Assessment should be individualized. |
| Organ or medical problems | May depend on affected genes; none are specified. Various issues are possible; none are specified. Do not infer particular complications from these labels. |
| Long-term health needs | Chronic supportive care may be needed. Chronic supportive care may be needed. Needs and severity can differ between people. |
Patient education highlights
- HighDiagnosis
A deletion finding is a genetic result; its meaning depends on size, genes, and clinical findings.
- HighIndividual variation
Features are not uniform, and this comparison does not predict one person's course.
- MediumCare
Management is supportive and directed to identified needs; no treatment dose is established here.